Evidence map›Paper›PMID 42117710›Full record

Trial reportMicrobiology spectrum2026

Adjuvant

Yuru Fu, Jie Dong, Leyi Xu, Yichi Zhang, Ziyu Jin, Kaiyue Yu, Ruixuan Zhou, Qiongya Zhao, Xingli Fan

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yuru Fu *School of Public Health, Hangzhou Medical College, Hangzhou, Zhejiang, China.
Jie Dong *Cancer Center, Department of Gastroenterology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.
Leyi XuSchool of Public Health, Hangzhou Medical College, Hangzhou, Zhejiang, China.
Yichi ZhangSchool of Basic Medicine and Forensic Medicine, Hangzhou Medical College, Hangzhou, Zhejiang, China.
Ziyu JinSchool of Basic Medicine and Forensic Medicine, Hangzhou Medical College, Hangzhou, Zhejiang, China.
Kaiyue YuSchool of Clinical Medicine, Hangzhou Medical College, Hangzhou, Zhejiang, China.
Ruixuan ZhouSchool of Public Health, Hangzhou Medical College, Hangzhou, Zhejiang, China.
Qiongya ZhaoSchool of Laboratory Medicine and Bioengineering, Hangzhou Medical College, Hangzhou, China.ORCID 0000-0001-9616-4787
Xingli FanSchool of Basic Medicine and Forensic Medicine, Hangzhou Medical College, Hangzhou, Zhejiang, China.ORCID 0000-0002-2136-3148

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gastrointestinal MicrobiomeHelicobacter InfectionsHelicobacter pyloriLactiplantibacillus plantarumProbioticsAdultAnti-Bacterial AgentsBacteriaBismuthDouble-Blind MethodDysbiosisFemaleHumansMaleMiddle AgedRNA, Ribosomal, 16SAnti-Bacterial AgentsBismuthRNA, Ribosomal, 16S16S rRNA sequencingadjuvant therapyclinical trialgut microbiotaHelicobacter pyloriLactiplantibacillus plantarum Lp05

Identifiers

PMID42117710
PMCPMC13227997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.